Few clinical environments face heavier prior authorization burdens than hematology-oncology. Treatments for conditions like leukemia, lymphoma, multiple myeloma, and hemophilia involve high-cost specialty drugs, complex regimens, and aggressive payer review processes.
For health system hematology practices, automating prior authorization is not just an efficiency play. It's a patient safety imperative.
The Unique Prior Authorization Challenge in Hematology
High-cost drug scrutiny: biologics like rituximab, ibrutinib, bortezomib, and CAR-T therapies are expensive enough that payers review them intensely, often requiring extensive step-therapy documentation and peer-to-peer review.
Regimen complexity: hematology patients frequently receive multi-drug regimens where every agent may require separate authorization with different review criteria. Chronic treatment cycles: patients on maintenance therapy require repeated authorizations as each treatment cycle begins—often on a 30-90 day cadence. Urgency and clinical risk: cancer treatment delays carry direct clinical consequences, making authorization bottlenecks a patient safety issue. Payer variability: patients may be covered by dozens of different commercial plans, each with unique criteria for the same drug.
How Manual Authorization Breaks Down
In practices that rely on manual authorization workflows, hematology team members typically spend hours each week compiling clinical documentation (diagnosis codes, pathology reports, prior treatment history) for each submission, submitting fax-based requests to payer portals, following up on pending authorizations by phone, appealing denied requests, and managing treatment delays while waiting for approvals.
In health systems running on Cerner, this work often happens outside the EHR entirely—in payer portals, fax queues, and spreadsheets—creating visibility gaps and increasing the risk that authorizations expire or are missed before treatment begins.
What Prior Authorization Automation Looks Like in Hematology
AI-powered prior authorization platforms can address each of these painpoints systematically. Automated request initiation: when a provider orders a treatment requiring authorization, the system automatically identifies the requirement, populates thenecessary clinical datafrom the EHR, and initiates the request without staff having to build submissions from scratch. Clinical documentation assembly: the platform pulls relevant clinical data from Cerner and assembles it into the payer's required format, reducing the risk of incomplete submissions. Payer-specific rules engine: for each payer, the system applies the appropriate coverage criteria and submission requirements, minimizing the back-and-forth caused by format or documentation mismatches. Status tracking and escalation: the system monitors pending authorizations and automatically follows uporescalates when approvals are delayed, ensuring no treatment start is missed due to aforgotten phonecall. Renewal management: for patients onrecurring treatment cycles, the platformautomatically initiates renewal requests in advance of expiration, eliminating last-minute scrambles before infusion appointments. Cerner integration: data flows directly between the EHR and theauthorization platform, eliminating duplicate data entry and keeping authorization status visible in the clinical workflow.
The Business and Clinical Impact
Health system hematology practices that have automated prior authorization report significant improvements. Faster approval turnaround: automated, complete submissions are approved faster than manual ones,often reducing average authorization time by 30 to 50 percent. Fewerdenials: complete documentation and payer-specific formatting reduces initial denial rates. Staff time reallocation: authorization staff move from manual submissions toexception handling andpeer-to-peer reviews. Treatment timeline reliability: fewer last-minute authorization crises mean chemotherapy schedules can be protected.
Building an Automated Authorization Workflow
The path to automation startswith mapping your current workflow: how are authorization requirements identified? Who builds submissions? How is status tracked? How are renewals managed?
Honey Health'sAI-powered prior authorization platform is designed for high-complexity specialty practices, with deep integration for Cerner-based health systems. Ithandles everything from initial submission to renewal management, givinghematologyteamstheinfrastructure to process authorizations at scale while protecting clinical timelines.
For health systems where hematology is a majorservice line, the ROI of automation is clear: fewer delays, fewer denials, and a staff team that spends itstime on exceptions—not routine paperwork.
